Research Database

427 studies found

Positive

340

79.6%

Negative

4.0%

Inconclusive

15.9%

Page 1 of 22

Review/Other

A comprehensive review of the multifaceted role of cannabinoid receptor type 2 in neurodegenerative and neuropsychiatric disorders

2025

Behavioral DisordersNeurodegenerative Issues

PositiveReview/Other

Decoding the Therapeutic Potential of Cannabis and Cannabinoids in Neurological Disorders

2025

Alzheimer's Disease

InconclusiveReview/Other

Intravitreal CBD-loaded niosomes enhance retinal neuroprotection in ischemic injury

2025

Neurodegenerative Issues

InconclusiveAnimal Study -

Upregulation of endocannabinoid signaling in vivo restores striatal synaptic plasticity and motor performance in Huntington's disease mice

2025

Depression

InconclusiveReview/Other

Hospital Visits for Cannabis Linked to Dementia Diagnoses

2025

Alzheimer's Disease

InconclusiveReview/Other

Commentary on the Role of Medicinal Cannabis in Healthy Aging and Neuroprotection

2025

Geriatric Conditions

PositiveAnimal Study - Veterinary Clinical Trial

The Therapeutic Potential and Ethical Implications of Medical Cannabis in Parkinson's Disease: Exploring Mitigation of Reliance on Deep Brain Stimulation

2025

Neurodegenerative Issues

NegativeReview/Other

Phytochemical Profile, Genotoxicity, and In Silico Toxicity Assessment, Antioxidant, and Neuroprotective Effects of <i>Clinopodium nepeta</i> Essential Oil: Inhibition of Acetylcholinesterase, Butyrylcholinesterase, and Monoamine Oxidase

2025

Alzheimer's Disease

Review/Other

Cognitive Effects of Cannabis Use Across the Lifespan: A Review for Clinical Practice

2025

Cannabis Adverse EffectsCognitive Dysfunction

InconclusiveReview/Other

Correction: Computational approach for the evaluation of sesquiterpene lactone as a modulator of cannabinoid receptor type 2 for neurodegenerative disease prophylactics

2025

Neurodegenerative Issues

PositiveAnimal Study -

Ginsenoside RK1 inhibits microglial activation and ROS production and alleviates vascular dementia in rats

2025

Cognitive Dysfunction

InconclusiveLaboratory Study -

Chemical Composition, Antioxidant, Antimicrobial, Antidiabetic, and Butyrylcholinesterase Inhibitory Activities in Vitro of the Essential Oil and Crude Extracts of the Aerial Parts of <i>Thymus ciliatus</i>

2025

Bacterial Infections

InconclusiveDouble Blind Clinical Trial

Sativex (nabiximols) for the treatment of Agitation & Aggression in Alzheimer’s dementia in UK nursing homes: a randomised, double-blind, placebo-controlled feasibility trial

2025

Alzheimer's Disease

InconclusiveReview/Other

PARRY-ROMBERG SYNDROME: POTENTIAL BENEFITS OF CANNABINOID THERAPY – CASE REPORT

2025

Neurodegenerative Issues

InconclusiveAnimal Study -

Behavioural effects of oral cannabidiol (CBD) treatment in the superoxide dismutase 1 G93 A (SOD1G93 A) mouse model of amyotrophic lateral sclerosis

2025

Anxiety

InconclusiveLaboratory Study -

Development of a human RPE In vitro model with AMD-like features reveals blue light-induced modulation of the endocannabinoid system

2025

Neurodegenerative Issues

InconclusiveReview/Other

Activation of central cannabinoid type 2 receptors, but not on peripheral immune cells, is required for endocannabinoid-mediated neuroprotection in Parkinson’s disease

2025

Neurodegenerative Issues

InconclusiveLaboratory Study -

Utilizing ADMET Analysis and Molecular Docking to Elucidate the Neuroprotective Mechanisms of a Cannabis-Containing Herbal Remedy (Suk-Saiyasna) in Inhibiting Acetylcholinesterase

2025

Alzheimer's Disease

InconclusiveReview/Other

USO DE CANNABIDIOL (CBD) EM DOENÇAS NEURODEGENERATIVAS E OUTRAS CONDIÇÕES NEUROLÓGICAS: ATUALIZAÇÕES EM EVIDÊNCIAS CLÍNICAS E PERSPECTIVAS TERAPÊUTICAS

2025

Autism

PositiveReview/Other

Full‐Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) Improves Symptoms of Rett Syndrome: An Open‐Label Study

2025

Anxiety

Command Palette

Research Database

A comprehensive review of the multifaceted role of cannabinoid receptor type 2 in neurodegenerative and neuropsychiatric disorders

Decoding the Therapeutic Potential of Cannabis and Cannabinoids in Neurological Disorders

Intravitreal CBD-loaded niosomes enhance retinal neuroprotection in ischemic injury

Upregulation of endocannabinoid signaling in vivo restores striatal synaptic plasticity and motor performance in Huntington's disease mice

Hospital Visits for Cannabis Linked to Dementia Diagnoses

Commentary on the Role of Medicinal Cannabis in Healthy Aging and Neuroprotection

The Therapeutic Potential and Ethical Implications of Medical Cannabis in Parkinson's Disease: Exploring Mitigation of Reliance on Deep Brain Stimulation

Phytochemical Profile, Genotoxicity, and In Silico Toxicity Assessment, Antioxidant, and Neuroprotective Effects of <i>Clinopodium nepeta</i> Essential Oil: Inhibition of Acetylcholinesterase, Butyrylcholinesterase, and Monoamine Oxidase

Cognitive Effects of Cannabis Use Across the Lifespan: A Review for Clinical Practice

Correction: Computational approach for the evaluation of sesquiterpene lactone as a modulator of cannabinoid receptor type 2 for neurodegenerative disease prophylactics

Ginsenoside RK1 inhibits microglial activation and ROS production and alleviates vascular dementia in rats

Chemical Composition, Antioxidant, Antimicrobial, Antidiabetic, and Butyrylcholinesterase Inhibitory Activities in Vitro of the Essential Oil and Crude Extracts of the Aerial Parts of <i>Thymus ciliatus</i>

Sativex (nabiximols) for the treatment of Agitation &amp; Aggression in Alzheimer’s dementia in UK nursing homes: a randomised, double-blind, placebo-controlled feasibility trial

PARRY-ROMBERG SYNDROME: POTENTIAL BENEFITS OF CANNABINOID THERAPY – CASE REPORT

Behavioural effects of oral cannabidiol (CBD) treatment in the superoxide dismutase 1 G93 A (SOD1G93 A) mouse model of amyotrophic lateral sclerosis

Development of a human RPE In vitro model with AMD-like features reveals blue light-induced modulation of the endocannabinoid system

Activation of central cannabinoid type 2 receptors, but not on peripheral immune cells, is required for endocannabinoid-mediated neuroprotection in Parkinson’s disease

Utilizing ADMET Analysis and Molecular Docking to Elucidate the Neuroprotective Mechanisms of a Cannabis-Containing Herbal Remedy (Suk-Saiyasna) in Inhibiting Acetylcholinesterase

USO DE CANNABIDIOL (CBD) EM DOENÇAS NEURODEGENERATIVAS E OUTRAS CONDIÇÕES NEUROLÓGICAS: ATUALIZAÇÕES EM EVIDÊNCIAS CLÍNICAS E PERSPECTIVAS TERAPÊUTICAS

Full‐Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) Improves Symptoms of Rett Syndrome: An Open‐Label Study

Sativex (nabiximols) for the treatment of Agitation & Aggression in Alzheimer’s dementia in UK nursing homes: a randomised, double-blind, placebo-controlled feasibility trial